IHS Chemical Week

Regions :: India/Pakistan

Hikma Acquires Stake in Indian API Firm

10:50 PM MDT | April 18, 2011 | Deepti Ramesh

Hikma Pharmaceuticals (London) says it has agreed to acquire a minority interest in privately held Unimark Remedies (Mumbai), a manufacturer of active pharmaceutical ingredients (API) and pharma intermediates, for $33.3 million. The transaction is expected to be completed next month. Unimark’s product range includes betalactams, cephalosporins, carbapenems and covers several therapeutic segments including cardiovascular, anti-asthma and anti-infectives. Unimark operates three API facilities, two of which are approved by the U.S. FDA, and two R&D...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa